[go: up one dir, main page]

CU24034B1 - Complejos de inclusión de pinocembrina con ciclodextrina o sus derivados - Google Patents

Complejos de inclusión de pinocembrina con ciclodextrina o sus derivados

Info

Publication number
CU24034B1
CU24034B1 CU2011000103A CU20110103A CU24034B1 CU 24034 B1 CU24034 B1 CU 24034B1 CU 2011000103 A CU2011000103 A CU 2011000103A CU 20110103 A CU20110103 A CU 20110103A CU 24034 B1 CU24034 B1 CU 24034B1
Authority
CU
Cuba
Prior art keywords
derivatives
inclusion complexes
pinocembrine
cyclodextrine
complexes
Prior art date
Application number
CU2011000103A
Other languages
English (en)
Other versions
CU20110103A7 (es
Inventor
Song Wu
Guanhua Du
Yan Qi
Mei Gao
Qingyun Yang
Hongmei Guang
Wei Li
Yuehua Wang
Yuanfeng Tong
Original Assignee
Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co
Inst Materia Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co, Inst Materia Medica filed Critical Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co
Publication of CU20110103A7 publication Critical patent/CU20110103A7/es
Publication of CU24034B1 publication Critical patent/CU24034B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Se proporcionan complejos de inclusión de pinocembrina con ciclodextrina o sus derivados y su preparación; los complejos de inclusión pueden utilizarse para hacer medicamentos.
CU2011000103A 2008-11-11 2011-05-11 Complejos de inclusión de pinocembrina con ciclodextrina o sus derivados CU24034B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2008/073011 WO2010054507A1 (zh) 2008-11-11 2008-11-11 松属素环糊精或环糊精衍生物包合物

Publications (2)

Publication Number Publication Date
CU20110103A7 CU20110103A7 (es) 2012-01-31
CU24034B1 true CU24034B1 (es) 2014-10-02

Family

ID=42169585

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2011000103A CU24034B1 (es) 2008-11-11 2011-05-11 Complejos de inclusión de pinocembrina con ciclodextrina o sus derivados

Country Status (16)

Country Link
US (1) US9949946B2 (es)
EP (1) EP2359861B1 (es)
JP (1) JP5413998B2 (es)
KR (1) KR101563308B1 (es)
AP (1) AP2011005707A0 (es)
AU (1) AU2008364165B2 (es)
BR (1) BRPI0823254A2 (es)
CA (1) CA2743006C (es)
CU (1) CU24034B1 (es)
EA (1) EA020784B1 (es)
ES (1) ES2438294T3 (es)
IL (2) IL212819A (es)
MX (1) MX2011004991A (es)
UA (1) UA99979C2 (es)
WO (1) WO2010054507A1 (es)
ZA (1) ZA201103244B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2377529A4 (en) * 2008-12-11 2013-05-22 Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd USE OF RACEMATES OF PINOCEMBRIN IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF STROKE
GR1007520B (el) * 2010-12-02 2012-02-02 Apivita - Καλλυντικα - Διαιτητικα - Φαρμακα Ανωνυμη Εμπορικη Και Βιοτεχνικη Εταιρεια, Ταυτοχρονη εκχυλιση και σχηματισμος συμπλοκων εγκλεισμου των δραστικων συστατικων της προπολης με υδροξυπροπυλο-β-κυκλοδεξτρινη
EP3607946B1 (en) 2012-03-19 2023-02-22 Buck Institute for Research on Aging App specific bace inhibitors (asbis) and uses thereof
US10202355B2 (en) 2013-02-12 2019-02-12 Buck Institute For Research On Aging Hydantoins that modulate bace-mediated app processing
WO2019046126A1 (en) 2017-08-28 2019-03-07 Achaogen, Inc. Aminoglycosides and uses thereof
WO2019194858A1 (en) 2018-04-03 2019-10-10 Achaogen, Inc. Modular synthesis of aminoglycosides
CN113766916B (zh) 2019-01-22 2024-04-05 艾奥维安制药公司 Mtorc调节剂及其用途
KR102356618B1 (ko) * 2021-11-17 2022-02-08 명지대학교 산학협력단 신규 포접복합체 및 이의 용도
CA3245419A1 (en) 2022-03-04 2023-09-07 Revagenix, Inc. Broad-spectrum aminoglycosides and their uses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
JP3269737B2 (ja) * 1994-08-31 2002-04-02 宇野醤油株式会社 食品保存料、およびその製造方法
JP2782335B2 (ja) * 1996-03-04 1998-07-30 株式会社武田薬化学研究所 プロポリスの水分散液
CN1424112A (zh) 2002-12-17 2003-06-18 上海医药工业研究院 难溶性药物的水溶性包合物及其制备方法
CN1285334C (zh) 2004-05-12 2006-11-22 中国医学科学院药物研究所 生松素在制备防治神经细胞损伤相关疾病药物中的应用
WO2006020163A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Skin care composition containing a flavonoid and vitamin b3
CN1739537A (zh) 2004-08-26 2006-03-01 张红军 灯盏花素环糊精包合物及其制剂
KR100601395B1 (ko) 2004-11-04 2006-07-18 한국식품연구원 수용성 프로폴리스 추출물 및 분말의 제조 방법
CN1311815C (zh) * 2005-05-08 2007-04-25 浙江大学 亚微米蜂胶微胶囊的制备方法
CN1879656B (zh) * 2006-04-27 2010-04-21 魏春华 固体水溶性蜂胶组合物及其制备方法

Also Published As

Publication number Publication date
MX2011004991A (es) 2011-07-29
JP2012508191A (ja) 2012-04-05
ES2438294T3 (es) 2014-01-16
EP2359861A4 (en) 2012-05-02
US20110218173A1 (en) 2011-09-08
JP5413998B2 (ja) 2014-02-12
UA99979C2 (uk) 2012-10-25
AU2008364165A1 (en) 2010-05-20
KR20110098906A (ko) 2011-09-02
IL212819A (en) 2015-07-30
ZA201103244B (en) 2011-12-28
IL212819A0 (en) 2011-07-31
CA2743006A1 (en) 2010-05-20
EP2359861A1 (en) 2011-08-24
CU20110103A7 (es) 2012-01-31
EP2359861B1 (en) 2013-09-11
AU2008364165B2 (en) 2015-01-29
WO2010054507A1 (zh) 2010-05-20
KR101563308B1 (ko) 2015-10-26
EA201100730A1 (ru) 2011-10-31
US9949946B2 (en) 2018-04-24
HK1155094A1 (en) 2012-08-03
AP2011005707A0 (en) 2011-06-30
EA020784B1 (ru) 2015-01-30
BRPI0823254A2 (pt) 2015-06-23
CA2743006C (en) 2016-02-09

Similar Documents

Publication Publication Date Title
CU24034B1 (es) Complejos de inclusión de pinocembrina con ciclodextrina o sus derivados
CY1117956T1 (el) N3-αντικατεστημενα-n1-sulfonyl-5-fluoropyrimidinone παραγωγα
SMT201500036B (it) Derivati di cromenone con attivita' antitumorale
SMT201600198B (it) Derivati di 1,2,4-triazina-4-ammina
GEAP201813723A (en) Anti-gcc antibody molecules and related compositions and methods
HRP20181493T1 (hr) Konjugati epsilon-polilizin i njihova primjena
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
HN2012000263A (es) Derivados n1-sulfonil-5-fluoropirimidinona
SMT201500316B (it) Derivati di benzotiazolo come agenti anticancro
ME03082B (me) 11-hidroksil-6-supsтituisani-derivati žučnih kiselina i njihovi aminoкiselinski konjugati као modulatori receptora za farnezoid х
CY1118062T1 (el) Συνθεσεις για την αντιμετωπιση της ναυτιας και του εμετου κεντρικης προελευσης
PL3564361T3 (pl) Organoid wątroby, jego zastosowanie i sposoby hodowlane jego otrzymywania
ECSP11011340A (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
MA32363B1 (fr) Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine.
UY33754A (es) Monobactamas
EP2820018A4 (en) AMIDO-BENZYL-SULFON AND SULFOXIDE DERIVATIVES
TR201908180T4 (tr) N1-asil- 5-floropirimidinon deriveleri.
SMT201600076B (it) Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo
BR112013010074A2 (pt) composição celulósica e produto
SMT201300067B (it) Applicazioni terapeutiche di derivati di chinazolindione
BRPI0913441A2 (pt) Composição prebiótica e métodos de produção e uso da mesma
SV2009003429A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
HRP20160965T1 (hr) Instant suhi rezanci i postupak za njihovu proizvodnju
SMT201600345B (it) Derivati benzochinonici come modulatori della funzione mitocondriale
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
FG Grant of patent